Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.

MLA

Espinosa, Mario, et al. “Pegylated Interferon (Alone or with Ribavirin) for Chronic Hepatitis C in Haemodialysis Population.” Kidney & Blood Pressure Research, vol. 40, no. 3, 2015, pp. 258–65. EBSCOhost, https://doi.org/10.1159/000368501.

APA

Espinosa, M., Hernàndez, J., Arenas, M. D., Carnicer, F., Caramelo, C., & Fabrizi, F. (2015). Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population. Kidney & Blood Pressure Research, 40(3), 258–265. https://doi.org/10.1159/000368501

Chicago

Espinosa, Mario, Jesùs Hernàndez, Maria Dolores Arenas, Fernando Carnicer, Carlos Caramelo, and Fabrizio Fabrizi. 2015. “Pegylated Interferon (Alone or with Ribavirin) for Chronic Hepatitis C in Haemodialysis Population.” Kidney & Blood Pressure Research 40 (3): 258–65. doi:10.1159/000368501.